Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

President Donald Trump on Monday reiterated his plans to impose levies in the “not too distant future” against pharmaceutical ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter ...

To mitigate the impact of potential tariffs, market diversification strategies are essential. Indian pharmaceutical firms can ...

In a letter to the Financial Times, pharma chief executives called for an EU drug pricing benchmark to challenge US levels ...

Norovirus GII.17 variants have overtaken GII.4 as the most prevalent strain and significantly increased norovirus outbreaks in the U.S. and European countries in 2024-2025Cocrystal Pharma's pan-viral ...

Pharmaceutical firm Shield Therapeutics has admitted that US tariffs spell risks and uncertainties for its business.

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal ...

WASHINGTON (Reuters) -U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported ...